AZN•benzinga•
AstraZeneca Plans $1.5B Manufacturing Facility For Antibody Drug Conjugates In Singapore, AstraZeneca Expects To Begin Design And Construction By The End Of 2024, With Targeted Operational Readiness From 2029
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2024 by benzinga